JANE STREET GROUP, LLC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 66 filers reported holding ONCOCYTE CORP in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q1 2023$8,791
-34.9%
24,806
-41.0%
0.00%
Q4 2022$13,500
-38.6%
42,068
+36.9%
0.00%
Q3 2022$22,000
-88.0%
30,722
-13.5%
0.00%
Q1 2021$184,000
+607.7%
35,501
+92.9%
0.00%
Q3 2020$26,000
-73.5%
18,400
-64.2%
0.00%
Q2 2020$98,000
-44.9%
51,367
-28.0%
0.00%
Q2 2019$178,000
+278.7%
71,342
+496.4%
0.00%
Q1 2019$47,00011,9630.00%
Other shareholders
ONCOCYTE CORP shareholders Q3 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 1,093,219$6,833,0001.15%
HUNTINGTON NATIONAL BANK 10$00.00%
CITIGROUP INC 642$4,0000.00%
Sonora Investment Management, LLC 50$00.00%
BARCLAYS PLC 206$1,0000.00%
BLACKROCK ADVISORS LLC 96$1,0000.00%
View complete list of ONCOCYTE CORP shareholders